Iridex (IRIX) EPS (Diluted) (QoQ) (2010 - 2026)
Iridex (IRIX) EPS (Diluted) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | Iridex | 15.45 Mn | 10.86 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -178.58% |
| Jan 3, 2026 | 88.25% |
| Sep 27, 2025 | -56.24% |
| Jun 28, 2025 | 41.28% |
| Mar 29, 2025 | -99.39% |
| Dec 28, 2024 | 56.64% |
| Sep 28, 2024 | 29.13% |
| Jun 29, 2024 | 22.82% |
| Mar 30, 2024 | -151.20% |
| Dec 30, 2023 | 485.17% |
| Sep 30, 2023 | 37.35% |
| Jul 1, 2023 | -32.06% |
| Apr 1, 2023 | -132.55% |
| Dec 31, 2022 | 463.06% |
| Oct 1, 2022 | 21.61% |
| Jul 2, 2022 | 6.35% |
| Apr 2, 2022 | -351.00% |
| Jan 1, 2022 | 143.84% |
| Oct 2, 2021 | -260.16% |
| Jul 3, 2021 | 160.97% |